Global Alpha-1 Antitrypsin Drugs Sales Market Report 2021

Global Alpha-1 Antitrypsin Drugs Sales Market Report 2021

Table of Contents
1 Alpha-1 Antitrypsin Drugs Market Overview
1.1 Alpha-1 Antitrypsin Drugs Product Scope
1.2 Alpha-1 Antitrypsin Drugs Segment by Type
1.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Parenteral
1.2.3 Inhalation
1.3 Alpha-1 Antitrypsin Drugs Segment by Application
1.3.1 Global Alpha-1 Antitrypsin Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Alpha-1 Antitrypsin Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Alpha-1 Antitrypsin Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Alpha-1 Antitrypsin Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Alpha-1 Antitrypsin Drugs Price Trends (2016-2027)
2 Alpha-1 Antitrypsin Drugs Estimates and Forecasts by Region
2.1 Global Alpha-1 Antitrypsin Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Alpha-1 Antitrypsin Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Alpha-1 Antitrypsin Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Alpha-1 Antitrypsin Drugs Estimates and Projections (2016-2027)
2.4.3 China Alpha-1 Antitrypsin Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Alpha-1 Antitrypsin Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Alpha-1 Antitrypsin Drugs Estimates and Projections (2016-2027)
2.4.6 India Alpha-1 Antitrypsin Drugs Estimates and Projections (2016-2027)
3 Global Alpha-1 Antitrypsin Drugs Competition Landscape by Players
3.1 Global Top Alpha-1 Antitrypsin Drugs Players by Sales (2016-2021)
3.2 Global Top Alpha-1 Antitrypsin Drugs Players by Revenue (2016-2021)
3.3 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2020)
3.4 Global Alpha-1 Antitrypsin Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Alpha-1 Antitrypsin Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Alpha-1 Antitrypsin Drugs Market Size by Type
4.1 Global Alpha-1 Antitrypsin Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Alpha-1 Antitrypsin Drugs Price by Type (2016-2021)
4.2 Global Alpha-1 Antitrypsin Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2022-2027)
5 Global Alpha-1 Antitrypsin Drugs Market Size by Application
5.1 Global Alpha-1 Antitrypsin Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Alpha-1 Antitrypsin Drugs Price by Application (2016-2021)
5.2 Global Alpha-1 Antitrypsin Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2022-2027)
6 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures
6.1 North America Alpha-1 Antitrypsin Drugs Sales by Company
6.1.1 North America Alpha-1 Antitrypsin Drugs Sales by Company (2016-2021)
6.1.2 North America Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021)
6.2 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Type
6.2.1 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Application
6.3.1 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2022-2027)
7 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures
7.1 Europe Alpha-1 Antitrypsin Drugs Sales by Company
7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Company (2016-2021)
7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021)
7.2 Europe Alpha-1 Antitrypsin Drugs Sales Breakdown by Type
7.2.1 Europe Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Alpha-1 Antitrypsin Drugs Sales Breakdown by Application
7.3.1 Europe 122 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 122 Sales Breakdown by Application (2022-2027)
8 China Alpha-1 Antitrypsin Drugs Market Facts & Figures
8.1 China Alpha-1 Antitrypsin Drugs Sales by Company
8.1.1 China Alpha-1 Antitrypsin Drugs Sales by Company (2016-2021)
8.1.2 China Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021)
8.2 China Alpha-1 Antitrypsin Drugs Sales Breakdown by Type
8.2.1 China Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2022-2027)
8.3 China Alpha-1 Antitrypsin Drugs Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)
9 Japan Alpha-1 Antitrypsin Drugs Market Facts & Figures
9.1 Japan Alpha-1 Antitrypsin Drugs Sales by Company
9.1.1 Japan Alpha-1 Antitrypsin Drugs Sales by Company (2016-2021)
9.1.2 Japan Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021)
9.2 Japan Alpha-1 Antitrypsin Drugs Sales Breakdown by Type
9.2.1 Japan Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Alpha-1 Antitrypsin Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Alpha-1 Antitrypsin Drugs Market Facts & Figures
10.1 Southeast Asia Alpha-1 Antitrypsin Drugs Sales by Company
10.1.1 Southeast Asia Alpha-1 Antitrypsin Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Alpha-1 Antitrypsin Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Alpha-1 Antitrypsin Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Alpha-1 Antitrypsin Drugs Market Facts & Figures
11.1 India Alpha-1 Antitrypsin Drugs Sales by Company
11.1.1 India Alpha-1 Antitrypsin Drugs Sales by Company (2016-2021)
11.1.2 India Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021)
11.2 India Alpha-1 Antitrypsin Drugs Sales Breakdown by Type
11.2.1 India Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2022-2027)
11.3 India Alpha-1 Antitrypsin Drugs Sales Breakdown by Application
11.3.1 India Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Alpha-1 Antitrypsin Drugs Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered
12.1.5 Baxter Recent Development
12.2 CSL Behring
12.2.1 CSL Behring Corporation Information
12.2.2 CSL Behring Business Overview
12.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Products Offered
12.2.5 CSL Behring Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Business Overview
12.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Grifols Alpha-1 Antitrypsin Drugs Products Offered
12.3.5 Grifols Recent Development
12.4 Kamada
12.4.1 Kamada Corporation Information
12.4.2 Kamada Business Overview
12.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kamada Alpha-1 Antitrypsin Drugs Products Offered
12.4.5 Kamada Recent Development
12.5 Abeona Therapeutics
12.5.1 Abeona Therapeutics Corporation Information
12.5.2 Abeona Therapeutics Business Overview
12.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Products Offered
12.5.5 Abeona Therapeutics Recent Development
12.6 Alnylam Pharmaceuticals
12.6.1 Alnylam Pharmaceuticals Corporation Information
12.6.2 Alnylam Pharmaceuticals Business Overview
12.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Products Offered
12.6.5 Alnylam Pharmaceuticals Recent Development
12.7 Applied Genetic Technologies Corp
12.7.1 Applied Genetic Technologies Corp Corporation Information
12.7.2 Applied Genetic Technologies Corp Business Overview
12.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Products Offered
12.7.5 Applied Genetic Technologies Corp Recent Development
12.8 Arrowhead Research Corporation
12.8.1 Arrowhead Research Corporation Corporation Information
12.8.2 Arrowhead Research Corporation Business Overview
12.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Products Offered
12.8.5 Arrowhead Research Corporation Recent Development
12.9 Baxalta
12.9.1 Baxalta Corporation Information
12.9.2 Baxalta Business Overview
12.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Baxalta Alpha-1 Antitrypsin Drugs Products Offered
12.9.5 Baxalta Recent Development
13 Alpha-1 Antitrypsin Drugs Manufacturing Cost Analysis
13.1 Alpha-1 Antitrypsin Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs
13.4 Alpha-1 Antitrypsin Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Alpha-1 Antitrypsin Drugs Distributors List
14.3 Alpha-1 Antitrypsin Drugs Customers
15 Market Dynamics
15.1 Alpha-1 Antitrypsin Drugs Market Trends
15.2 Alpha-1 Antitrypsin Drugs Drivers
15.3 Alpha-1 Antitrypsin Drugs Market Challenges
15.4 Alpha-1 Antitrypsin Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Alpha-1 Antitrypsin Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Alpha-1 Antitrypsin Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Alpha-1 Antitrypsin Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Alpha-1 Antitrypsin Drugs Revenue Share by Region (2016-2021)
Table 8. Global Alpha-1 Antitrypsin Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Alpha-1 Antitrypsin Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Alpha-1 Antitrypsin Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Alpha-1 Antitrypsin Drugs Sales Share by Company (2016-2021)
Table 14. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Alpha-1 Antitrypsin Drugs Revenue Share by Company (2016-2021)
Table 16. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2020)
Table 17. Global Alpha-1 Antitrypsin Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Alpha-1 Antitrypsin Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2016-2021)
Table 23. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2022-2027)
Table 26. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2022-2027)
Table 28. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2016-2021)
Table 31. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2022-2027)
Table 35. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2022-2027)
Table 37. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Alpha-1 Antitrypsin Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Alpha-1 Antitrypsin Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Alpha-1 Antitrypsin Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Alpha-1 Antitrypsin Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2022-2027)
Table 62. China Alpha-1 Antitrypsin Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2016-2021)
Table 64. China Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Table 68. China Alpha-1 Antitrypsin Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2022-2027)
Table 70. China Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Table 72. China Alpha-1 Antitrypsin Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Alpha-1 Antitrypsin Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Alpha-1 Antitrypsin Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Alpha-1 Antitrypsin Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Alpha-1 Antitrypsin Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Alpha-1 Antitrypsin Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Alpha-1 Antitrypsin Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2022-2027)
Table 98. India Alpha-1 Antitrypsin Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2016-2021)
Table 100. India Alpha-1 Antitrypsin Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Table 104. India Alpha-1 Antitrypsin Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2022-2027)
Table 106. India Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Table 108. India Alpha-1 Antitrypsin Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2022-2027)
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Baxter Alpha-1 Antitrypsin Drugs Product
Table 114. Baxter Recent Development
Table 115. CSL Behring Corporation Information
Table 116. CSL Behring Description and Business Overview
Table 117. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. CSL Behring Alpha-1 Antitrypsin Drugs Product
Table 119. CSL Behring Recent Development
Table 120. Grifols Corporation Information
Table 121. Grifols Description and Business Overview
Table 122. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Grifols Alpha-1 Antitrypsin Drugs Product
Table 124. Grifols Recent Development
Table 125. Kamada Corporation Information
Table 126. Kamada Description and Business Overview
Table 127. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Kamada Alpha-1 Antitrypsin Drugs Product
Table 129. Kamada Recent Development
Table 130. Abeona Therapeutics Corporation Information
Table 131. Abeona Therapeutics Description and Business Overview
Table 132. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product
Table 134. Abeona Therapeutics Recent Development
Table 135. Alnylam Pharmaceuticals Corporation Information
Table 136. Alnylam Pharmaceuticals Description and Business Overview
Table 137. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product
Table 139. Alnylam Pharmaceuticals Recent Development
Table 140. Applied Genetic Technologies Corp Corporation Information
Table 141. Applied Genetic Technologies Corp Description and Business Overview
Table 142. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product
Table 144. Applied Genetic Technologies Corp Recent Development
Table 145. Arrowhead Research Corporation Corporation Information
Table 146. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Arrowhead Research Corporation Description and Business Overview
Table 148. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product
Table 149. Arrowhead Research Corporation Recent Development
Table 150. Baxalta Corporation Information
Table 151. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Baxalta Description and Business Overview
Table 153. Baxalta Alpha-1 Antitrypsin Drugs Product
Table 154. Baxalta Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Alpha-1 Antitrypsin Drugs Distributors List
Table 158. Alpha-1 Antitrypsin Drugs Customers List
Table 159. Alpha-1 Antitrypsin Drugs Market Trends
Table 160. Alpha-1 Antitrypsin Drugs Market Drivers
Table 161. Alpha-1 Antitrypsin Drugs Market Challenges
Table 162. Alpha-1 Antitrypsin Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha-1 Antitrypsin Drugs Product Picture
Figure 2. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Parenteral Product Picture
Figure 4. Inhalation Product Picture
Figure 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Drugstore Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Alpha-1 Antitrypsin Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Alpha-1 Antitrypsin Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Alpha-1 Antitrypsin Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Alpha-1 Antitrypsin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Alpha-1 Antitrypsin Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Alpha-1 Antitrypsin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Alpha-1 Antitrypsin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Alpha-1 Antitrypsin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Alpha-1 Antitrypsin Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Alpha-1 Antitrypsin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Alpha-1 Antitrypsin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Alpha-1 Antitrypsin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Alpha-1 Antitrypsin Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Alpha-1 Antitrypsin Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Alpha-1 Antitrypsin Drugs Players Market Share by Revenue in Alpha-1 Antitrypsin Drugs: 2016 & 2020
Figure 28. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Alpha-1 Antitrypsin Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Alpha-1 Antitrypsin Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 34. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 35. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 36. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 37. China Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 38. China Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 39. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 40. Japan Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 43. India Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 44. India Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Alpha-1 Antitrypsin Drugs
Figure 47. Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs
Figure 48. Alpha-1 Antitrypsin Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs